Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orchestra BioMed Holdings (OBIO) Cash from Investing Activities: 2022-2024

Historic Cash from Investing Activities for Orchestra BioMed Holdings (OBIO) over the last 3 years, with Dec 2024 value amounting to $13.1 million.

  • Orchestra BioMed Holdings' Cash from Investing Activities fell 7027.11% to -$38.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$13.0 million, marking a year-over-year decrease of 125.97%. This contributed to the annual value of $13.1 million for FY2024, which is 22.48% up from last year.
  • According to the latest figures from FY2024, Orchestra BioMed Holdings' Cash from Investing Activities is $13.1 million, which was up 22.48% from $10.7 million recorded in FY2023.
  • In the past 5 years, Orchestra BioMed Holdings' Cash from Investing Activities registered a high of $13.1 million during FY2024, and its lowest value of -$64.1 million during FY2022.
  • In the last 3 years, Orchestra BioMed Holdings' Cash from Investing Activities had a median value of $10.7 million in 2023 and averaged -$13.4 million.
  • Data for Orchestra BioMed Holdings' Cash from Investing Activities shows a peak YoY skyrocketed of 116.67% (in 2023) over the last 5 years.
  • Over the past 3 years, Orchestra BioMed Holdings' Cash from Investing Activities (Yearly) stood at -$64.1 million in 2022, then surged by 116.67% to $10.7 million in 2023, then rose by 22.48% to $13.1 million in 2024.